Randolph Bishop, MD
Neurological Surgery · Savannah, GANPI 1659360600
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $161,848 of the $169,837 with a category attached, or 95.3%. Amendia, Inc. accounts for 95.3% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $162,198 and has fallen 98.6% since, to $2,290 in 2025. Among neurological surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $617.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amendia, Inc.$162K
- Medtronic$2K
- Boston Scientific$1K
- Abbott$1K
- Intelivation Technologies, LLC$1K
- Spinal Elements, Inc.$274
- plus $2K from 31 others
What the payments were for
- Royalty or licence$161,84895%
- Consulting fees$1,0001%
- Travel & lodging$1,3481%
- Food & beverage$5,6403%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Savannah T$161,848
- MAZOR X SYSTEM$1,473
- Medical Device$249
How this compares
$169,837 in reported general payments places this provider in the 90th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 208 | $2,509 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 155 | $1,664 |
| Methylprednisolone | 43 | $382 |
| Cyclobenzaprine Hcl | 51 | $368 |
| Tizanidine Hcl | 26 | $165 |
| Gabapentin | 19 | $138 |
| Tramadol Hcl | 19 | $111 |
| Ibuprofen | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Savannah
- Jay HowingtonSavannah$162K
- James LindleySavannah$24K
- Regis HaidAtlanta$25.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- Betsy GrunchGainesville$1.1M
- James RobinsonAtlanta$993K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.